QiShenYiQi pill inhibits atherosclerosis by promoting TTC39B-LXR mediated reverse cholesterol transport in liver-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

QiShenYiQi pill inhibits atherosclerosis by promoting TTC39B-LXR mediated reverse cholesterol transport in liver

Published:2024-01 Issue: Volume:123 Page:155192
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

Wang Tao-tao,Yang Cheng-yong,Peng Li,Li Li,Chen Nan-ting,Feng Xue,Xie Jing,Wu Ting-chun,Xu Tao,Chen Yun-zhi

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference36 articles.

1. Free cholesterol bioavailability and atherosclerosis;Abe;Curr. Atheroscler. Rep.,2022

2. The protective role of ubiquinol-10 against formation of lipid hydroperoxides in human seminal fluid;Alleva;Mol. Aspects Med.,1997

3. A comparison of two LDL cholesterol targets after ischemic stroke;Amarenco;N. Engl. J. Med.,2020

4. Regulation of cholesterol 7α-hydroxylase mRNA expression in C57BL/6 mice fed an atherogenic diet;Ando;Atherosclerosis,2005

5. A piRNA pathway primed by individual transposons is linked to de novo DNA methylation in mice;Aravin;Mol. Cell.,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shuanghuanglian Volatile Oil Exerts Antipyretic, Anti-inflammatory, and Antibacterial Synergistic Effects Through Multiple Pathways;Journal of Ethnopharmacology;2024-09

2. Dan-shen Yin promotes bile acid metabolism and excretion to prevent atherosclerosis via activating FXR/BSEP signaling pathway;Journal of Ethnopharmacology;2024-08

3. LOC646762 Is Involved in Adipogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells;ACS Omega;2024-02-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3